Abstract
Purpose
To evaluate the linguistic and psychometric properties of the Functional Living Index-Cancer (FLIC) in assessing the quality of life of Chinese cancer patients.
Methods
The English FLIC was translated into Traditional Chinese by the standard forward–backward procedure. After cognitive debriefing, a Traditional Chinese FLIC was administered to 500 cancer patients in a major public hospital in Hong Kong. Of which, 200 were invited to complete the questionnaire in 2 weeks. To identify a scale structure appropriate to Chinese, exploratory and confirmatory factor analyses were performed on two randomly split halves of the sample.
Results
We identified five scales of the Traditional Chinese FLIC which assess the physical, psychological, hardship, nausea and social aspects. These five scales and the overall scale demonstrated satisfactory fit and had the alpha coefficient ranged from 0.68 to 0.92. The intra-class correlation coefficient ranged from 0.67 to 0.88. In addition, all FLIC scales were negatively associated with the Eastern Cooperative Oncology Group performance status and, also except for the psychological scale, had lower scores in patients who were treated by chemotherapy.
Conclusions
The Traditional Chinese FLIC is an appropriate health indicator for Chinese cancer patients.
Abbreviations
- CFA:
-
Confirmatory factor analysis
- ECOG:
-
Eastern Cooperative Oncology Group
- EFA:
-
Exploratory factor analysis
- EORTC QLQ:
-
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire
- FACT-G:
-
Functional Assessment of Cancer Therapy-General
- FLIC:
-
Functional Living Index-Cancer
- ICC:
-
Intraclass correlation coefficient
- RMSEA:
-
Root mean square error of approximation
- SD:
-
Standard deviation
- SRMR:
-
Standardized root mean square residual
References
Johnson, J. R., & Temple, R. (1985). Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treatment Reports, 69(10), 1155–1159.
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984). Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. Journal of Clinical Oncology, 2(5), 472–483.
Laenen, A., & Alonso, A. (2010). The Functional Living Index-Cancer: Estimating its reliability based on clinical trial data. Quality of Life Research, 19(1), 103–109. doi:10.1007/s11136-009-9568-x.
King, M. T., Dobson, A. J., & Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index-Cancer (FLIC) and the quality of life questionnaire core module (QLQ-C30). Journal of Clinical Epidemiology, 49(1), 21–29.
Goh, C. R., Lee, K. S., Tan, T. C., Wang, T. L., Tan, C. H., Wong, J., et al. (1996). Measuring quality of life in different cultures: Translation of the Functional Living Index for Cancer (FLIC) into Chinese and Malay in Singapore. Annals Academy of Medicine Singapore, 25(3), 323–334.
Cheung, Y. B., Goh, C., Thumboo, J., Khoo, K. S., & Wee, J. (2005). Variability and sample size requirements of quality-of-life measures: A randomized study of three major questionnaires. Journal of Clinical Oncology, 23(22), 4936–4944.
Morrow, G. R., Lindke, J., & Black, P. (1992). Measurement of quality of life in patients: Psychometric analyses of the Functional Living Index-Cancer (FLIC). Quality of Life Research, 1(5), 287–296.
Ruckdeschel, J. C., & Piantadosi, S. (1994). Quality of life in lung cancer surgical adjuvant trials. Chest, 106(6 Suppl), 324S–328S.
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., et al. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5(6), 649–655.
Fong, D. Y., Lam, C. L., Mak, K. K., Lo, W. S., Lai, Y. K., Ho, S. Y., et al. (2010). The Short Form-12 Health Survey was a valid instrument in Chinese adolescents. Journal of Clinical Epidemiology, 63(9), 1020–1029. doi:10.1016/j.jclinepi.2009.11.011.
Costello, A. B., & Osborne, J. W. (2005). Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical Assessment, Research & Evaluation, 10(7), 1–9.
Hu, L. T., & Bentler, P. M. (1998). Fit indices in covariance structure modeling: Sensitivity to underparameterized model misspecification. Psychological Methods, 3(4), 424–453.
Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55.
Nunnally, J. C. (1978). Psychometric theory (2d ed., McGraw-Hill series in psychology). New York: McGraw-Hill.
Schipper, H., & Levitt, M. (1985). Measuring quality of life: Risks and benefits. Cancer Treatment Reports, 69(10), 1115–1125.
Bektas, H. A., & Akdemir, N. (2008). Reliability and validity of the Functional Living Index-Cancer in Turkish cancer patients. Cancer Nursing, 31(1), E1–E7. doi:10.1097/01.NCC.0000305684.51884.1f.
Cheung, Y. B., Ng, G. Y., Wong, L. C., Koo, W. H., Tan, E. H., Tay, M. H., et al. (2003). Measuring quality of life in Chinese cancer patients: A new version of the Functional Living Index for Cancer (Chinese). Annals Academy of Medicine Singapore, 32(3), 376–380.
Acknowledgments
This work was supported by the Small Project Funding of The University of Hong Kong. Y.B.C. was supported by the Singapore Ministry of Health’s National Medical Research Council under its Clinician Scientist Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fong, D.Y.T., Lee, A.H.K., Tung, S.Y. et al. The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients. Qual Life Res 23, 311–316 (2014). https://doi.org/10.1007/s11136-013-0456-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0456-z